Obesity treatment: Australia urged to subsidise GLP-1 drugs amid rising rates

Add articles to your saved list and come back to them any time. The World Health Organisation (WHO) has urged governments to make GLP-1 medicines such as Ozempic more affordable, publishing new guidelines that endorse the high-profile drugs
Read more...